company background image
6MA

Ambea DB:6MA Stock Report

Last Price

kr4.83

Market Cap

kr458.6m

7D

1.9%

1Y

-37.1%

Updated

25 Apr, 2022

Data

Company Financials +
6MA fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance1/6
Financial Health2/6
Dividends3/6

6MA Stock Overview

Ambea AB (publ) provides housing, support, education, and personnel for health and social care for the elderly and people with disabilities in Sweden, Norway, and Denmark.

Ambea Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ambea
Historical stock prices
Current Share Pricekr4.83
52 Week Highkr7.93
52 Week Lowkr3.96
Beta1.3
1 Month Change10.27%
3 Month Change1.68%
1 Year Change-37.08%
3 Year Change-31.27%
5 Year Changen/a
Change since IPO-40.62%

Recent News & Updates

Shareholder Returns

6MADE HealthcareDE Market
7D1.9%-2.4%-1.5%
1Y-37.1%-11.6%-12.4%

Return vs Industry: 6MA underperformed the German Healthcare industry which returned -9.8% over the past year.

Return vs Market: 6MA underperformed the German Market which returned -10.6% over the past year.

Price Volatility

Is 6MA's price volatile compared to industry and market?
6MA volatility
6MA Average Weekly Movement5.8%
Healthcare Industry Average Movement5.3%
Market Average Movement6.3%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market3.4%

Stable Share Price: 6MA is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 6MA's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199626,000Mark Jensenhttps://www.ambea.se

Ambea AB (publ) provides housing, support, education, and personnel for health and social care for the elderly and people with disabilities in Sweden, Norway, and Denmark. The company operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The Nytida segment comprises residential facilities, support for individuals and families, schools for children, young people and adults with disabilities or psychosocial problems, and day services.

Ambea Fundamentals Summary

How do Ambea's earnings and revenue compare to its market cap?
6MA fundamental statistics
Market Capkr4.78b
Earnings (TTM)kr237.00m
Revenue (TTM)kr11.48b

20.2x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6MA income statement (TTM)
Revenuekr11.48b
Cost of Revenuekr8.62b
Gross Profitkr2.86b
Other Expenseskr2.62b
Earningskr237.00m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

May 04, 2022

Earnings per share (EPS)2.51
Gross Margin24.92%
Net Profit Margin2.06%
Debt/Equity Ratio58.1%

How did 6MA perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

46%

Payout Ratio

Does 6MA pay a reliable dividends?

See 6MA dividend history and benchmarks
When do you need to buy 6MA by to receive an upcoming dividend?
Ambea dividend dates
Ex Dividend DateMay 13 2022
Dividend Pay DateMay 19 2022
Days until Ex dividend17 days
Days until Dividend pay date23 days

Does 6MA pay a reliable dividends?

See 6MA dividend history and benchmarks

Valuation

Is Ambea undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: 6MA (€4.83) is trading below our estimate of fair value (€16.72)

Significantly Below Fair Value: 6MA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 6MA is good value based on its PE Ratio (20.2x) compared to the German Healthcare industry average (21.5x).

PE vs Market: 6MA is poor value based on its PE Ratio (20.2x) compared to the German market (18.8x).


Price to Earnings Growth Ratio

PEG Ratio: 6MA is good value based on its PEG Ratio (0.8x)


Price to Book Ratio

PB vs Industry: 6MA is good value based on its PB Ratio (1.1x) compared to the DE Healthcare industry average (1.5x).


Future Growth

How is Ambea forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


25.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6MA's forecast earnings growth (25.3% per year) is above the savings rate (-0.05%).

Earnings vs Market: 6MA's earnings (25.3% per year) are forecast to grow faster than the German market (8.6% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 6MA's revenue (4.2% per year) is forecast to grow slower than the German market (5.3% per year).

High Growth Revenue: 6MA's revenue (4.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 6MA's Return on Equity is forecast to be low in 3 years time (12.3%).


Past Performance

How has Ambea performed over the past 5 years?

Past Performance Score

1/6

Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


13.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 6MA has a large one-off loss of SEK108.0M impacting its December 31 2021 financial results.

Growing Profit Margin: 6MA's current net profit margins (2.1%) are lower than last year (3.2%).


Past Earnings Growth Analysis

Earnings Trend: 6MA's earnings have grown by 13.1% per year over the past 5 years.

Accelerating Growth: 6MA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 6MA had negative earnings growth (-34%) over the past year, making it difficult to compare to the Healthcare industry average (34%).


Return on Equity

High ROE: 6MA's Return on Equity (5.2%) is considered low.


Financial Health

How is Ambea's financial position?

Financial Health Score

2/6

Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 6MA's short term assets (SEK1.8B) do not cover its short term liabilities (SEK4.3B).

Long Term Liabilities: 6MA's short term assets (SEK1.8B) do not cover its long term liabilities (SEK7.8B).


Debt to Equity History and Analysis

Debt Level: 6MA's net debt to equity ratio (56.2%) is considered high.

Reducing Debt: 6MA's debt to equity ratio has reduced from 109.2% to 58.1% over the past 5 years.

Debt Coverage: 6MA's debt is well covered by operating cash flow (45.9%).

Interest Coverage: 6MA's interest payments on its debt are not well covered by EBIT (2.7x coverage).


Balance Sheet


Dividend

What is Ambea current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.27%

Current Dividend Yield

Upcoming Dividend Payment

TodayApr 26 2022Ex Dividend DateMay 13 2022Dividend Pay DateMay 19 20226 days from Ex DividendBuy in the next 17 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: 6MA's dividend (2.27%) is higher than the bottom 25% of dividend payers in the German market (1.28%).

High Dividend: 6MA's dividend (2.27%) is low compared to the top 25% of dividend payers in the German market (3.88%).


Stability and Growth of Payments

Stable Dividend: 6MA has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 6MA's dividend payments have increased, but the company has only paid a dividend for 4 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (45.9%), 6MA's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (9.8%), 6MA's dividend payments are thoroughly covered by cash flows.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average management tenure


CEO

Mark Jensen (50 yo)

1.08yrs

Tenure

kr9,666,531

Compensation

Mr. Mark Jensen is Chief Executive Officer and President at Ambea AB (publ) since March 2021. He served as Chief Executive Officer of MTR Nordic at MTR Corporation Limited until February 28, 2021. He serve...


CEO Compensation Analysis

Compensation vs Market: Mark's total compensation ($USD993.92K) is about average for companies of similar size in the German market ($USD969.60K).

Compensation vs Earnings: Insufficient data to compare Mark's compensation with company performance.


Leadership Team

Experienced Management: 6MA's management team is considered experienced (3.3 years average tenure).


Board Members

Experienced Board: 6MA's board of directors are considered experienced (5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 6MA insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Ambea AB (publ)'s employee growth, exchange listings and data sources


Key Information

  • Name: Ambea AB (publ)
  • Ticker: 6MA
  • Exchange: DB
  • Founded: 1996
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: kr4.779b
  • Listing Market Cap: kr458.574m
  • Shares outstanding: 94.53m
  • Website: https://www.ambea.se

Number of Employees


Location

  • Ambea AB (publ)
  • Evenemangsgatan 21, 6 tr
  • Box 1565
  • Solna
  • Stockholm County
  • 171 29
  • Sweden

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/04/25 00:00
End of Day Share Price2022/04/22 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.